AP NEWS

The Global MicroRNA (miRNA) Market: Size, Share & Trends Analysis (2018-2025) - Thermofisher Scientific, Agilent Technologies, Merck, Qiagen, and NanoString Technologies are Dominating - ResearchAndMarkets.com

November 7, 2018

DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “MicroRNA (miRNA) Market Size, Share & Trends Analysis Report By Research Tools, By Application (Cancer, Neurological Disease, Immunological Disorder, Infectious Diseases) By End-use, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global microRNA (abbreviated miRNA) market size is expected to reach USD 626.27 million by 2025, posting a CAGR of 18.6% during the forecast period.A significant role of microRNAs in regulating gene expression. Their rapid adoption in development of diagnostic & prognostic tools for various cancer types is anticipated to provide a fillip to the market.

Recent innovations in miRNA applications such as their use as potential biomarkers in advanced diagnostics have accelerated new product development. Based on existing technologies used in gene analysis such as microarrays, qRT-PCR, and sequencing, new products are being developed for better usage of miRNA. These are designed to overcome challenges faced when working with miRNA.

Key Findings

Growing competition among miRNA-based therapeutic companies to develop tests & biomarkers for clinical use is likely to boost the demand for miRNA detection services.Rapid high-quality results coupled with declining sequencing prices are poised to drive adoption of NGS services for miRNA functional studies.Some key companies present in the market are Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); and NanoString Technologies Inc. The prominence of these players can be attributed to their well-established technical capabilities in other fields of biotechnology.Market Dynamics Drivers Recent Innovations in Applications of MiRNAsHigh Investments in MiRNA and Rising R&D Initiatives for Development of New Diagnostic Tests & TherapeuticsSuccess of MiRNA in Clinical TrialsTechnological Advancements to Support Nucleic Acid StudiesExponentially Declining Cost of Sequencing Restraints High Cost Associated With MicroRNA Kits and Other ProductsChallenges in Handling RNA & In-House Development of Assays for MicroRNA DetectionPoor Reproducibility of Research and Specificity of ProductsLimited Life Science Research Infrastructure in Emerging MarketsNeed of Skilled Personnel

Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 microRNA Market Variables, Trends& Scope

Chapter 4 microRNA Market: Products & Services Estimates & Trend Analysis

Chapter 5 microRNA Market: Application Estimates & Trend Analysis

Chapter 6 microRNA Market: End-use Estimates & Trend Analysis

Chapter 7 microRNA Market: Regional Estimates & Trend Analysis

Chapter 8 Competitive Landscape

Merck KGaAQIAGENDharmacon, a Horizon Discovery Group Co.Thermo Fisher Scientific, Inc.SynlogicGeneCopoeia, Inc.New England BiolabsQuantabioNanoString Technologies, Inc.BioGenexSeqMatic LLCMiltenyi BiotecSistemic Scotland LimitedBiodynamics Laboratory, Inc.OriGene Technologies, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/zl7rr7/the_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005497/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/07/2018 08:04 AM/DISC: 11/07/2018 09:34 AM

http://www.businesswire.com/news/home/20181107005497/en

AP RADIO
Update hourly